Il-9 receptor variants, useful in treating and diagnosing...

C - Chemistry – Metallurgy – 12 – N

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C12N 15/24 (2006.01) A61K 38/20 (2006.01) C07K 14/715 (2006.01) C12N 15/12 (2006.01) C12Q 1/02 (2006.01) C12Q 1/68 (2006.01)

Patent

CA 2689842

This invention relates to the diagnosis, treatment and methods for discovery of new therapeutics for atopic asthma and related disorders based on variants of Asthma Associated Factor (2). One embodiment of the invention is a variant of AAF2, wherein codon 173 is deleted resulting in the loss of glutamine 173 from the mature protein precursor. This single amino acid deletion results in a non-functional AAF2 protein and therefore the presence of this phenotype should be associated with less evidence of atopic asthma. Correspondingly, the lack of susceptibility to an asthmatic, atopic phenotype is characterized by the loss of glutamine at codon 173. The invention includes isolated DNA molecules which are variants of the wild type sequence as well as the proteins encoded by such DNA and the use of such DNA molecules and expressed protein in the diagnosis and treatment of atopic asthma.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Il-9 receptor variants, useful in treating and diagnosing... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Il-9 receptor variants, useful in treating and diagnosing..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Il-9 receptor variants, useful in treating and diagnosing... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1438099

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.